Investing.com -- Shares of SFS Group AG (SWX:SFSN) fell by 3% as the company's preliminary second-half and full-year results for fiscal year 2024 showed a slight decline in sales and a miss against ...

Investing.com -- UBS Global Research has upgraded Trainline (LON: TRNT) to a "buy" rating, citing improved fundamentals and ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...